Inventor
GOLDBERG SHALOM
US13 patents
Patents
13 patentsUS10196446B2Feb 5, 2019
Cysteine engineered fibronectin type III domain binding molecules
JANSSEN BIOTECH INC16 citations92
US11576986B2Feb 14, 2023
Macrocyclic chelators and methods of use thereof
JANSSEN BIOTECH INC9 citations85
US10662235B2May 26, 2020
Cysteine engineered fibronectin type III domain binding molecules
JANSSEN BIOTECH INC4 citations72
US10844122B2Nov 24, 2020
Prostate specific membrane antigen (PSMA) bispecific binding agents and uses thereof
JANSSEN BIOTECH INC4 citations68
US12453785B2Oct 28, 2025
Macrocyclic chelators and methods of use thereof
JANSSEN BIOTECH INC0 citations62
US12054534B2Aug 6, 2024
Prostate specific membrane antigen binding fibronectin type iii domains
JANSSEN BIOTECH INC0 citations60
US11702475B2Jul 18, 2023
Cysteine engineered fibronectin type III domain binding molecules
JANSSEN BIOTECH INC0 citations60
US11072663B2Jul 27, 2021
Cysteine engineered fibronectin type III domain binding molecules
JANSSEN BIOTECH INC0 citations60
US12227593B2Feb 18, 2025
Site-specific conjugation of glycosylated monoclonal antibodies with transglutaminase
JANSSEN BIOTECH INC0 citations56
US11987641B2May 21, 2024
Anti-PSMA antibodies and uses thereof
JANSSEN BIOTECH INC0 citations56
US10844111B2Nov 24, 2020
Prostate specific membrane antigen binding fibronectin type III domains
JANSSEN BIOTECH INC0 citations49
US12240790B2Mar 4, 2025
Radiolabeling of polypeptides
JANSSEN BIOTECH INC0 citations47
US12084475B2Sep 10, 2024
Methods for site specific conjugation of proteins containing glycosylated Fc domains
JANSSEN BIOTECH INC0 citations46